A three-step synthesis of enantiomerically pure (R) and (S)-trans nerolidol from commercially available E,E-fanesol is described. Trans nerolidol is an abundant sesquiterpene in many plant species, almost enantiomerically pure; however, the configuration of chirality is S. There is no natural resource for R-trans nerolidol, which has recently been identified as a pheromone component of the fruit spotting bug Amblypelta lutescens. The simple syntheses reported here will make enantiomerically pure R-and S-trans nerolidol and homologues available for further research and ultimately for use in integrated pest management strategies comprising pheromones.
Nerolidol and related oxygenated sesquiterpenes are common to plant genera of the family Myrtaceae. Among nerolidol isomers, trans (S)-nerolidol has been identified as an attractant of spider mites [1] and a pheromone of the dung beetle [2] . Nerolidol isomers function as insect attractants [3, 4] , as antifeedants [5] [6] [7] , and as larvicidal agents [8] . For use in controlling spider mites, a major crop pest, farnesol and trans (S)-nerolidol are applied to the plants in a spray mixture that also contains a miticide, and has recently been registered as a biopesticide with the United States Environmental Protection Agency. Because of the increasing interest in enantiomerically and chemically pure nerolidol and in an effort to make them readily available to other researchers, we report here a simple, three step synthesis of trans (R)-and (S)-nerolidol from commercially available (E,E)-farnesol. The ready availability of these compounds as single enantiomers should also enhance their potential for exploitation for integrated pest management. Trans (R)-and (S)-nerolidol were readily prepared from E,Efarnesol using epoxidation conditions [9, 10] . Sharpless asymmetric epoxidation was carried out using either (-) or (+) diethyl tartrate to give (2R,3R) and (2S,3S) epoxy farnesol, respectively; which were quantitatively converted to labile triflate and then reduced with activated zinc in diethyl ether-acetic acid to produce enantiomerically pure either trans (R)-or (S)-nerolidol in excellent yields (>80%). Several syntheses of these compounds have been reported, but most have required either several steps or tedious chromatography [11] . Another short synthesis [12] reported enantiomerically pure nerolidol using Te (II) in the concluding step. However, careful handling and variation in the yields of the final product prompted us to optimize the reaction sequence for multigram asymmetric synthesis of nerolidol. In summary, the short and simple synthesis of trans (R)-and (S) -nerolidol described in this communication should make these compounds readily accessible to researchers. Furthermore, the route can be readily adapted to produce homologues of any desired chain length by the straightforward chiral epoxidation and subsequent reduction of epoxy-alcohols.
Experimental
General: Dichloromethane was distilled from calcium hydride (CaH) under argon. 1 H-and 13 C-NMR spectra (400 and 100 MHz, respectively) were obtained in CDC1 3 solutions with a Bruker-400 spectrometer. Mass spectra were obtained with a Hewlett-Packard 5973 (70 eV) mass selective detector interfaced to a HP 6890 gas chromatograph fitted with a DB5-MS column (30 m x 0.25 mm id) with helium as carrier gas. Products were purified by vacuum flash chromatography on silica gel (E. Merck, 230-400 mesh). Unless specified, all synthetic reagents were purchased from Sigma-Aldrich (Milwaukee, USA) with reported chemical purity between 95-99%.
Synthesis of (2R,3R)-epoxyfarnesol:
A solution of E,E-farnesol (1.1 g, 5 mmol) in dichloromethane (10 mL) and t-butyl hydroperoxide in dichloromethane (2.5 mL, 11 mmol, 4.0M) were sequentially added under argon to a stirred dichloromethane (35 mL) solution of diethyl (-) -tartrate (0.95 mL, 5.5 mmol, 1.1 eq.) and Ti (O-i-Pr) 4 (1.6 mL, 5.4 mmol, 1.05 eq) at -50 o C. The resulting mixture was stirred for 1 h at -50°C, diluted with a 10% aqueous tartaric acid solution (10 mL) and warmed to room temperature over 2 h. The mixture was washed with water (3x10 mL) and extracted with dichloromethane (3 x 20 mL). The combined organic layers were washed with brine, dried over anhydrous MgSO 4 , and the solvent removed. Le & Chauhan purified by CC on silica gel (4:l n-hexane-EtOAc) to obtain chiral epoxide (985 mg, 84%) as a colorless oil: + 6.58 (c 3.5, CHC1 3 ); The 1 H and 13 C NMR spectra were identical to those previously reported [12] .
Synthesis of R-(-)-nerolidol:
To the above epoxy alcohol (952 mg, 4 mmol) in dichloromethane (25 mL) at -20°C was added pyridine (941 mg, 12 mmol, 3 eq) followed by neat trifluoromethanesulfonic anhydride (1.65 g, 6 mmol, 1.5 eq). The mixture was stirred at this temperature for 2 h, diluted with diethyl ether (15 mL), washed with water (2 x 10 mL), saturated CuSO 4 solution (4 x 10 mL), and water (2 x 10 mL), dried, and concentrated under reduced pressure to give a labile, reddish syrup (8.60 g, 97%). This labile triflate was redissolved in 10 mL of dry diethyl ether and the solution was cannulated to a flask containing activated zinc powder (prepared by reported procedure, 1.2 g, 20 mmol, 5 eq). Acetic acid (0.5 mL) was added to this solution and stirred at room temperature for 1 h and then eluted from a short column of Florisil with diethyl ether. The ethereal solution was concentrated and the crude product was purified by CC on silica gel (10:l n-hexane-EtOAc) to afford 3R (-)nerolidol (756 mg. 86%) as a colorless oil. -16.38 (c 2.8, CHC1 3 ) (lit  -17.90 (c 1.15, EtOH); [13] . The 1 H and 13 C NMR spectra were identical to those previously reported [12] .
Synthesis of S-(+)-nerolidol:
Repetition of the foregoing sequence using diethyl (+)-tartrate proceeded analogously to produce (2S,3S)epoxyfarnesol from E,E-farnesol, which was converted to triflate and then reduced to trans nerolidol with the 3S configuration. Chiral gas chromatography analyses revealed co-elution of synthetic trans (S)-nerolidol with plant derived (S)-nerolidol from Melaleuca quinquenervia oil (synthetic trans (R)-nerolidol eluted prior to (S)-nerolidol).
